Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.46
ABC's Cash-to-Debt is ranked lower than
51% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. ABC: 0.46 )
Ranked among companies with meaningful Cash-to-Debt only.
ABC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.46 Max: 1.7
Current: 0.46
0.06
1.7
Equity-to-Asset 0.08
ABC's Equity-to-Asset is ranked lower than
100% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. ABC: 0.08 )
Ranked among companies with meaningful Equity-to-Asset only.
ABC' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.36  Med: 0.15 Max: 0.38
Current: 0.08
-0.36
0.38
Debt-to-Equity 1.42
ABC's Debt-to-Equity is ranked lower than
88% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.56 vs. ABC: 1.42 )
Ranked among companies with meaningful Debt-to-Equity only.
ABC' s Debt-to-Equity Range Over the Past 10 Years
Min: -88.72  Med: 0.55 Max: 41.25
Current: 1.42
-88.72
41.25
Debt-to-EBITDA 3.49
ABC's Debt-to-EBITDA is ranked lower than
59% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. ABC: 3.49 )
Ranked among companies with meaningful Debt-to-EBITDA only.
ABC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.96  Med: 1.3 Max: 3.49
Current: 3.49
0.96
3.49
Interest Coverage 11.52
ABC's Interest Coverage is ranked lower than
63% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. ABC: 11.52 )
Ranked among companies with meaningful Interest Coverage only.
ABC' s Interest Coverage Range Over the Past 10 Years
Min: 11.52  Med: 13.53 Max: 15.47
Current: 11.52
11.52
15.47
Piotroski F-Score: 5
Altman Z-Score: 4.61
Beneish M-Score: -2.21
WACC vs ROIC
8.33%
68.79%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 1.16
ABC's Operating Margin % is ranked lower than
75% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. ABC: 1.16 )
Ranked among companies with meaningful Operating Margin % only.
ABC' s Operating Margin % Range Over the Past 10 Years
Min: 0.98  Med: 1.23 Max: 1.67
Current: 1.16
0.98
1.67
Net Margin % 0.54
ABC's Net Margin % is ranked lower than
73% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. ABC: 0.54 )
Ranked among companies with meaningful Net Margin % only.
ABC' s Net Margin % Range Over the Past 10 Years
Min: -0.1  Med: 0.6 Max: 0.97
Current: 0.54
-0.1
0.97
ROE % 32.37
ABC's ROE % is ranked higher than
93% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. ABC: 32.37 )
Ranked among companies with meaningful ROE % only.
ABC' s ROE % Range Over the Past 10 Years
Min: -10.74  Med: 18.36 Max: 104.01
Current: 32.37
-10.74
104.01
ROA % 2.39
ABC's ROA % is ranked lower than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. ABC: 2.39 )
Ranked among companies with meaningful ROA % only.
ABC' s ROA % Range Over the Past 10 Years
Min: -0.56  Med: 3.21 Max: 4.8
Current: 2.39
-0.56
4.8
ROC (Joel Greenblatt) % 46.72
ABC's ROC (Joel Greenblatt) % is ranked higher than
84% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.92 vs. ABC: 46.72 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ABC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 46.72  Med: 139.58 Max: 185.13
Current: 46.72
46.72
185.13
3-Year Revenue Growth Rate 10.80
ABC's 3-Year Revenue Growth Rate is ranked higher than
53% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. ABC: 10.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ABC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -27.3  Med: 15.5 Max: 28.5
Current: 10.8
-27.3
28.5
3-Year EBITDA Growth Rate 18.80
ABC's 3-Year EBITDA Growth Rate is ranked higher than
73% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.60 vs. ABC: 18.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ABC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -31.1  Med: 16.5 Max: 25.8
Current: 18.8
-31.1
25.8
3-Year EPS without NRI Growth Rate 11.00
ABC's 3-Year EPS without NRI Growth Rate is ranked higher than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. ABC: 11.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ABC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 17.4 Max: 44.4
Current: 11
0
44.4
GuruFocus has detected 3 Warning Signs with AmerisourceBergen Corp ABC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ABC's 30-Y Financials

Financials (Next Earnings Date: 2018-08-03)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

ABC Guru Trades in Q2 2017

David Dreman 4,645 sh (New)
Joel Greenblatt 287,336 sh (+444.29%)
Mario Gabelli 10,765 sh (+30.25%)
Richard Pzena 2,602 sh (+4.00%)
Barrow, Hanley, Mewhinney & Strauss 676 sh (unchged)
Seth Klarman Sold Out
Paul Tudor Jones 2,793 sh (-0.25%)
Ken Fisher 67,736 sh (-0.33%)
Arnold Van Den Berg 107,606 sh (-0.59%)
Manning & Napier Advisors, Inc 36,660 sh (-16.17%)
First Pacific Advisors 114,890 sh (-25.63%)
Ray Dalio 21,760 sh (-75.51%)
» More
Q3 2017

ABC Guru Trades in Q3 2017

Steven Cohen 914,579 sh (New)
Seth Klarman 188,850 sh (New)
Mario Gabelli 17,500 sh (+62.56%)
Joel Greenblatt 344,774 sh (+19.99%)
David Dreman 4,645 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss Sold Out
Ray Dalio Sold Out
Paul Tudor Jones Sold Out
Arnold Van Den Berg 107,061 sh (-0.51%)
Manning & Napier Advisors, Inc 36,220 sh (-1.20%)
Ken Fisher 66,678 sh (-1.56%)
Richard Pzena 2,433 sh (-6.50%)
First Pacific Advisors 32,500 sh (-71.71%)
» More
Q4 2017

ABC Guru Trades in Q4 2017

Ray Dalio 18,399 sh (New)
George Soros 5,000 sh (New)
Pioneer Investments 176,354 sh (New)
Seth Klarman 1,434,565 sh (+659.63%)
Richard Pzena 3,278 sh (+34.73%)
Mario Gabelli 17,500 sh (unchged)
David Dreman Sold Out
Ken Fisher 62,744 sh (-5.90%)
Arnold Van Den Berg 98,156 sh (-8.32%)
Joel Greenblatt 285,921 sh (-17.07%)
First Pacific Advisors 13,700 sh (-57.85%)
Steven Cohen 301,259 sh (-67.06%)
» More
Q1 2018

ABC Guru Trades in Q1 2018

Larry Robbins 971,936 sh (New)
Ray Dalio 197,132 sh (+971.43%)
Richard Pzena 4,920 sh (+50.09%)
Mario Gabelli 17,500 sh (unchged)
George Soros Sold Out
Ken Fisher 61,796 sh (-1.51%)
Seth Klarman 1,317,216 sh (-8.18%)
Joel Greenblatt 257,237 sh (-10.03%)
Pioneer Investments 154,834 sh (-12.20%)
First Pacific Advisors 4,400 sh (-67.88%)
Steven Cohen 95,400 sh (-68.33%)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Seth Klarman 2018-03-31 Reduce -8.18%0.11%$84.01 - $105.48 $ 84.34-12%1,317,216
Joel Greenblatt 2018-03-31 Reduce -10.03%0.04%$84.01 - $105.48 $ 84.34-12%257,237
Ken Fisher 2018-03-31 Reduce -1.51%$84.01 - $105.48 $ 84.34-12%61,796
Richard Pzena 2018-03-31 Add 50.09%$84.01 - $105.48 $ 84.34-12%4,920
George Soros 2018-03-31 Sold Out 0.01%$84.01 - $105.48 $ 84.34-12%0
Seth Klarman 2017-12-31 Add 659.63%1.14%$73.23 - $93.79 $ 84.342%1,434,565
Joel Greenblatt 2017-12-31 Reduce -17.07%0.07%$73.23 - $93.79 $ 84.342%285,921
Arnold Van Den Berg 2017-12-31 Reduce -8.32%0.1%$73.23 - $93.79 $ 84.342%98,156
Ken Fisher 2017-12-31 Reduce -5.90%$73.23 - $93.79 $ 84.342%62,744
George Soros 2017-12-31 New Buy0.01%$73.23 - $93.79 $ 84.342%5,000
Richard Pzena 2017-12-31 Add 34.73%$73.23 - $93.79 $ 84.342%3,278
David Dreman 2017-12-31 Sold Out 0.21%$73.23 - $93.79 $ 84.342%0
Joel Greenblatt 2017-09-30 Add 19.99%0.07%$78.04 - $95.22 $ 84.34-1%344,774
Seth Klarman 2017-09-30 New Buy0.2%$78.04 - $95.22 $ 84.34-1%188,850
Arnold Van Den Berg 2017-09-30 Reduce -0.51%0.01%$78.04 - $95.22 $ 84.34-1%107,061
Ken Fisher 2017-09-30 Reduce -1.56%$78.04 - $95.22 $ 84.34-1%66,678
Mario Gabelli 2017-09-30 Add 62.56%$78.04 - $95.22 $ 84.34-1%17,500
Richard Pzena 2017-09-30 Reduce -6.50%$78.04 - $95.22 $ 84.34-1%2,433
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Sold Out $78.04 - $95.22 $ 84.34-1%0
Joel Greenblatt 2017-06-30 Add 444.29%0.31%$80.94 - $96.38 $ 84.34-5%287,336
Arnold Van Den Berg 2017-06-30 Reduce -0.59%0.01%$80.94 - $96.38 $ 84.34-5%107,606
Ken Fisher 2017-06-30 Reduce -0.33%$80.94 - $96.38 $ 84.34-5%67,736
Mario Gabelli 2017-06-30 Add 30.25%$80.94 - $96.38 $ 84.34-5%10,765
David Dreman 2017-06-30 New Buy0.24%$80.94 - $96.38 $ 84.34-5%4,645
Richard Pzena 2017-06-30 Add 4.00%$80.94 - $96.38 $ 84.34-5%2,602
Seth Klarman 2017-06-30 Sold Out 0.53%$80.94 - $96.38 $ 84.34-5%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:CAH, XKRX:091990, NAS:HSIC, HKSE:01099, SHSE:601607, NYSE:MCK, TSE:7459, SZSE:002589, SHSE:600056, SZSE:200028, LSE:UDG, SHSE:600763, NAS:PDCO, NZSE:EBO, SHSE:600090, NYSE:PBH, LSE:CLIN, SHSE:603368, TSE:7476, NYSE:OMI » details
Traded in other countries:ABG.Germany,
Headquarter Location:USA
AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada.

AmerisourceBergen is one of three major pharmaceutical distributors in the U.S., with highly efficient distribution assets. The firm's activities include procurement, inventory management, reimbursement consulting, sales forecasts, and logistics services. The firm is also a wholesale leader within the high-growth specialty distribution niche.

Guru Investment Theses on AmerisourceBergen Corp

Keeley Funds Comments on AmerisourceBergen Corp - Oct 30, 2017

AmerisourceBergen Corporation (NYSE:ABC) is a leading provider of drug distribution and other related services designed to reduce healthcare costs and improve patient outcomes. e company lagged after reporting lackluster scal third quarter earnings (ending June) and reducing its revenue guidance for the balance of the year due to brand in ation. In addition, investors were disappointed that AmerisourceBergen held fast to its previously stated view that generic drug pricing will decline in the high single digits and that generic drug de ation is not improving. We, however, remain con dent because of our view that AmerisourceBergen has a superior book of business compared to its peers, remains reasonably attractive from a valuation standpoint, and has several other growth businesses such as animal health.



From Keeley All Cap Value Fund's third quarter 2017 commentary.



Check out Keeley Asset Management Corp latest stock trades

Top Ranked Articles about AmerisourceBergen Corp

Larry Robbins’ Glenview Capital Management Starts 5 Positions in 1st Quarter Firm releases quarterly portfolio
Glenview Capital Management, founded in 2000 by Larry Robbins (Trades, Portfolio), disclosed on Wednesday it established positions in Express Scripts Holding Co. (NASDAQ:ESRX), T-Mobile US Inc. (NASDAQ:TMUS), AmerisourceBergen Corp. (NYSE:ABC), Humana Inc. (NYSE:HUM) and Facebook Inc. (NASDAQ:FB) during the first quarter. Read more...
Merger Arbitrage Positions Dominate Seth Klarman's Equity Portfolio Klarman is betting on several deals to complete
Over the past few days, hedge fund investors with more than $100 million have been filing their 13F reports with the SEC, updating the regulator on their positions' movements during the first quarter of 2018. Read more...
8 Stocks Richard Pzena Continues to Buy Chubb tops the list
Richard Pzena (Trades, Portfolio), the founder and co-chief investment officer of Pzena Investment Management, bought shares of the following stocks in both the first quarter of 2018 and fourth quarter of 2017. Read more...
Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group — What Drives Growth in Today's Competitive Landscape
How to Generate Better Insight Ways to obtain different and improved understanding
I had the pleasure to sit down and discuss my value investing journey with a group of friends earlier this month. During the conversation, one of them asked this great question: “So how do you know that you have generated differentiated and better insight?” Read more...
Recent Analysis Shows Horizon Bancorp, Hyster-Yale Materials Handling, Lydall, AmerisourceBergen, Netflix, and Visa Market Influences — Renewed Outlook, Key Drivers of Growth
Valuing Uncertainties When you are 10 years into an era where growth stocks have outperformed value stocks, stock promoters turn from fundamentals to futuristic fantasies
Valuing uncertainties Read more...
Walgreens Slips on Earnings Miss Despite Accelerating Revenues Company records impairment charges and equity investment losses, dragging down GAAP earnings
Walgreens Boots Alliance Inc. (NASDAQ:WBA) said that although fiscal first-quarter revenues increased 7.9% year over year, net earnings based on generally accepted accounting principles tumbled 22.1%. Read more...
Jabil in Green Pre-Market Friday The company surpasses estimates
U.S. stocks will open with gains on Friday and close the week with gains, as the major indexes are near record levels. Read more...
Analysis: Positioning to Benefit within Kirby, AmerisourceBergen, Celgene, Sabre, Noble Energy, and Idera Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results

Ratios

vs
industry
vs
history
PE Ratio 21.95
ABC's PE Ratio is ranked lower than
60% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.00 vs. ABC: 21.95 )
Ranked among companies with meaningful PE Ratio only.
ABC' s PE Ratio Range Over the Past 10 Years
Min: 10.31  Med: 17.12 Max: 1712.67
Current: 21.95
10.31
1712.67
Forward PE Ratio 13.11
ABC's Forward PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.99 vs. ABC: 13.11 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 21.95
ABC's PE Ratio without NRI is ranked lower than
60% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.94 vs. ABC: 21.95 )
Ranked among companies with meaningful PE Ratio without NRI only.
ABC' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.93  Med: 15.36 Max: 1468
Current: 21.95
9.93
1468
Price-to-Owner-Earnings 14.25
ABC's Price-to-Owner-Earnings is ranked higher than
89% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.94 vs. ABC: 14.25 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ABC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.95  Med: 11.37 Max: 477.72
Current: 14.25
4.95
477.72
PB Ratio 5.83
ABC's PB Ratio is ranked lower than
91% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.12 vs. ABC: 5.83 )
Ranked among companies with meaningful PB Ratio only.
ABC' s PB Ratio Range Over the Past 10 Years
Min: 1.67  Med: 3.97 Max: 35.62
Current: 5.83
1.67
35.62
PS Ratio 0.12
ABC's PS Ratio is ranked higher than
93% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. ABC: 0.12 )
Ranked among companies with meaningful PS Ratio only.
ABC' s PS Ratio Range Over the Past 10 Years
Min: 0.07  Med: 0.13 Max: 0.2
Current: 0.12
0.07
0.2
Price-to-Free-Cash-Flow 27.15
ABC's Price-to-Free-Cash-Flow is ranked higher than
52% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. ABC: 27.15 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ABC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.6  Med: 10.17 Max: 50.52
Current: 27.15
4.6
50.52
Price-to-Operating-Cash-Flow 17.62
ABC's Price-to-Operating-Cash-Flow is ranked higher than
58% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.02 vs. ABC: 17.62 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ABC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.24  Med: 8.86 Max: 466.27
Current: 17.62
4.24
466.27
EV-to-EBIT 25.08
ABC's EV-to-EBIT is ranked lower than
77% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.52 vs. ABC: 25.08 )
Ranked among companies with meaningful EV-to-EBIT only.
ABC' s EV-to-EBIT Range Over the Past 10 Years
Min: -154.4  Med: 9.2 Max: 354.8
Current: 25.08
-154.4
354.8
EV-to-EBITDA 16.30
ABC's EV-to-EBITDA is ranked lower than
65% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. ABC: 16.30 )
Ranked among companies with meaningful EV-to-EBITDA only.
ABC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 8.4 Max: 732.4
Current: 16.3
5.4
732.4
EV-to-Revenue 0.13
ABC's EV-to-Revenue is ranked higher than
95% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. ABC: 0.13 )
Ranked among companies with meaningful EV-to-Revenue only.
ABC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.1 Max: 0.2
Current: 0.13
0.1
0.2
PEG Ratio 2.19
ABC's PEG Ratio is ranked lower than
64% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. ABC: 2.19 )
Ranked among companies with meaningful PEG Ratio only.
ABC' s PEG Ratio Range Over the Past 10 Years
Min: 0.68  Med: 1.15 Max: 198.29
Current: 2.19
0.68
198.29
Shiller PE Ratio 31.98
ABC's Shiller PE Ratio is ranked lower than
86% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.63 vs. ABC: 31.98 )
Ranked among companies with meaningful Shiller PE Ratio only.
ABC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.19  Med: 30.15 Max: 85.54
Current: 31.98
16.19
85.54
Current Ratio 0.94
ABC's Current Ratio is ranked lower than
96% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. ABC: 0.94 )
Ranked among companies with meaningful Current Ratio only.
ABC' s Current Ratio Range Over the Past 10 Years
Min: 0.85  Med: 1.24 Max: 1.74
Current: 0.94
0.85
1.74
Quick Ratio 0.48
ABC's Quick Ratio is ranked lower than
94% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. ABC: 0.48 )
Ranked among companies with meaningful Quick Ratio only.
ABC' s Quick Ratio Range Over the Past 10 Years
Min: 0.37  Med: 0.52 Max: 0.71
Current: 0.48
0.37
0.71
Days Inventory 28.01
ABC's Days Inventory is ranked higher than
76% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. ABC: 28.01 )
Ranked among companies with meaningful Days Inventory only.
ABC' s Days Inventory Range Over the Past 10 Years
Min: 22.26  Med: 25.4 Max: 28.01
Current: 28.01
22.26
28.01
Days Sales Outstanding 25.81
ABC's Days Sales Outstanding is ranked higher than
92% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 60.84 vs. ABC: 25.81 )
Ranked among companies with meaningful Days Sales Outstanding only.
ABC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.6  Med: 19.6 Max: 25.81
Current: 25.81
17.6
25.81
Days Payable 62.29
ABC's Days Payable is ranked lower than
54% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. ABC: 62.29 )
Ranked among companies with meaningful Days Payable only.
ABC' s Days Payable Range Over the Past 10 Years
Min: 39.24  Med: 47.37 Max: 62.4
Current: 62.29
39.24
62.4

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.80
ABC's Dividend Yield % is ranked lower than
51% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. ABC: 1.80 )
Ranked among companies with meaningful Dividend Yield % only.
ABC' s Dividend Yield % Range Over the Past 10 Years
Min: 0.35  Med: 1.17 Max: 1.97
Current: 1.8
0.35
1.97
Dividend Payout Ratio 0.39
ABC's Dividend Payout Ratio is ranked higher than
78% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. ABC: 0.39 )
Ranked among companies with meaningful Dividend Payout Ratio only.
ABC' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.1  Med: 0.18 Max: 0.89
Current: 0.39
0.1
0.89
3-Year Dividend Growth Rate 15.80
ABC's 3-Year Dividend Growth Rate is ranked higher than
68% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. ABC: 15.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
ABC' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 17.4 Max: 81.7
Current: 15.8
0
81.7
Forward Dividend Yield % 1.79
ABC's Forward Dividend Yield % is ranked lower than
55% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. ABC: 1.79 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.77
ABC's 5-Year Yield-on-Cost % is ranked higher than
54% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.97 vs. ABC: 4.77 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
ABC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.93  Med: 3.1 Max: 5.22
Current: 4.77
0.93
5.22
3-Year Average Share Buyback Ratio 0.60
ABC's 3-Year Average Share Buyback Ratio is ranked higher than
80% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. ABC: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ABC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -75.8  Med: 1.5 Max: 9.9
Current: 0.6
-75.8
9.9

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.75
ABC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
85% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. ABC: 0.75 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ABC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.77 Max: 8.94
Current: 0.75
0.32
8.94
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.05
ABC's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
83% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.99 vs. ABC: 2.05 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
ABC' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.42  Med: 0.78 Max: 67.28
Current: 2.05
0.42
67.28
Price-to-Median-PS-Value 0.90
ABC's Price-to-Median-PS-Value is ranked lower than
67% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. ABC: 0.90 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ABC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54  Med: 1.07 Max: 2.09
Current: 0.9
0.54
2.09
Price-to-Peter-Lynch-Fair-Value 0.91
ABC's Price-to-Peter-Lynch-Fair-Value is ranked higher than
50% of the 16 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.23 vs. ABC: 0.91 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ABC' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.58  Med: 1.04 Max: 10.96
Current: 0.91
0.58
10.96
Earnings Yield (Greenblatt) % 3.97
ABC's Earnings Yield (Greenblatt) % is ranked lower than
63% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.16 vs. ABC: 3.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ABC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -0.7  Med: 10.7 Max: 16.7
Current: 3.97
-0.7
16.7
Forward Rate of Return (Yacktman) % 29.24
ABC's Forward Rate of Return (Yacktman) % is ranked higher than
94% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.37 vs. ABC: 29.24 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ABC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -19.9  Med: 22.5 Max: 29.3
Current: 29.24
-19.9
29.3

More Statistics

Revenue (TTM) (Mil) $159,327.35
EPS (TTM) $ 3.84
Beta1.06
Volatility29.26%
52-Week Range $71.90 - 106.27
Shares Outstanding (Mil)219.80

Analyst Estimate

Sep18 Sep19 Sep20
Revenue (Mil $) 166,331 177,832 187,384
EBIT (Mil $) 2,015 2,169 2,293
EBITDA (Mil $) 2,370 2,540 2,598
EPS ($) 6.37 7.06 7.79
EPS without NRI ($) 6.37 7.06 7.79
EPS Growth Rate
(Future 3Y To 5Y Estimate)
8.30%
Dividends per Share ($) 1.50 1.53 1.60

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}